Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells

Area of Science:

• Stem cell biology
• Hepatocyte differentiation
• Regenerative medicine

Background:

• Human induced pluripotent stem cells (hiPSCs) are valuable for pharmaceutical research and cell therapy.
• Generating mature hepatocytes from hiPSCs in vitro remains a significant challenge.
• Variability in hiPSC line hepatic differentiation potential is poorly understood.

Purpose of the Study:

• To develop an improved protocol for hiPSC-derived hepatocyte differentiation.
• To investigate the impact of hiPSC origin and derivation method on hepatic differentiation efficiency.
• To identify key factors influencing differentiation variability among hiPSC lines.

Main Methods:

• Compared hepatic differentiation efficiency across 28 hiPSC lines.
• Included hiPSC lines from diverse somatic cell origins (e.g., peripheral blood, dermal fibroblasts).
• Assessed differentiation across various hiPSC derivation methods (retroviral, Sendai, episomal).

Main Results:

• hiPSC origin, not derivation method, influenced hepatic differentiation.
• Peripheral blood-derived hiPSC clones generally showed higher differentiation efficiency than dermal fibroblast-derived clones.
• Individual donor variability was the primary determinant of differentiation propensity, overriding cell origin effects.

Conclusions:

• Donor-specific factors are critical determinants of hiPSC hepatic differentiation potential.
• Selection of hiPSC lines should consider individual donor characteristics for consistent differentiation outcomes.
• Understanding donor variability is essential for advancing hiPSC applications in hepatology and cell therapy.